External Grants Funding Opportunity Announcements Print this page

A current listing of external grants and government funding opportunities* identified as relevant to the CIMIT community.

Grants are listed in cronological order of application submission opening/due dates.

(Page last updated: 8/12/10)

* CIMIT and all affiliated entities do not endorse the information from external links, nor are they responsible for the availability, accuracy, or content of these sites.

---

NSF Opportunities for Promoting Understanding through Synthesis (OPUS)

Full Proposal Deadline(s): July 07, 2010; July 7, Annually Thereafter;
January 07, 2011; January 7, Annually Thereafter

Website: NSF.gov posting

Purpose: All four clusters within the Division of Environmental Biology ( Population and Community Ecology, Ecosystem Science, Evolutionary Processes and Systematic Biology and Biodiversity Inventories) encourage the submission of proposals aimed at synthesizing a body of related research projects conducted by a single individual or a group of investigators over an extended period. OPUS proposals will often be appropriately submitted in mid-to-late career, but will also be appropriate early enough in a career to produce unique, integrated insight useful both to the scientific community and to the development of the investigator's future work. In cases where multiple scientists have worked collaboratively, an OPUS award will provide support for collaboration on a synthesis.

---

NSF Neural Systems

Application Deadline: July 12, 2010, Annually Thereafter

Website: NSF.gov posting

Purpose: The Neural Systems Cluster focuses on how complex functions arise from communication among the cellular elements of the nervous system and from interactions with other physiological systems and the environment.  The Cluster encourages a systems biology approach to understand how emergent neural properties such as robustness, adaptability and resilience arise in the context of environmental, genetic and evolutionary influences.

Investigations may range over time scales from the physiological to the evolutionary.  Studies may range in complexity from molecular and cellular processes to the behaviors that emerge from these processes and the feedback that these behaviors exert on the system.  The use of comparative and evolutionary studies, as well as the development of novel theoretical, computational, and transdisciplinary approaches to guide and instruct experimental design, are particularly encouraged.

---

NSF Physiological and Structural Systems

Application Deadline: July 12, 2010, Annually Thereafter

Website: NSF.gov posting

Purpose: The Physiological and Structural Systems Cluster supports research aimed at furthering the understanding of organisms as integrated units of biological organization.  The Cluster considers proposals focused on interacting physiological and structural systems, their environmental and evolutionary contexts, and how these components are constrained by their integration into the whole organism.  Projects that use systems approaches to understand why particular patterns of architecture and regulatory control have emerged as general organismal properties are particularly encouraged.  Understanding how and why emergent organismal properties such as robustness, adaptability and resilience arise in the context of environmental, genetic, biochemical and morphological variation are of interest.  The Cluster encourages model building to augment traditional experimental approaches in order to guide research on complex functional networks.  Multidisciplinary approaches to the study of organismal systems including research at the interfaces of biology, physics, chemistry, mathematics, computer science and engineering are encouraged in each of the following areas: Symbiosis, Defense and Self-recognition; Processes, Structures and Integrity; Organism-Environment Interactions.

---

NIH International Neuroscience Fellowship (F05)

Letters of Intent Receipt Date(s): July 16, 2010, 2011, 2012
Applications Due Date(s): August 16, 2010, 2011, 2012 

Website: NIH.gov posting

Purpose: The goal of the International Neuroscience Fellowship (INF) is to advance the training of qualified foreign neuroscientists and clinicians at the early or mid-career level, by enhancing their basic, translational or clinical research skills in a research setting in the United States (U.S.).  This program aims to strengthen the intellectual capital of neuroscience research in international institutions.  Awardees are expected to pursue future independent and productive careers, which stimulate research in the neurosciences on a global scale. 

---

NIH NIAID Clinical Trial Planning Grant (R34)

Application Due Date(s) for AIDS & Non-AIDS: July 22, 2010; September 13, 2010; January 13, 2011; May 13, 2011; September 13, 2011; January 13, 2012; May 14, 2012; September 13, 2012; January 14, 2013

Website: NIH.gov posting

Purpose: This Funding Opportunity Announcement (FOA) issued by the National Institute of Allergy and Infectious Diseases (NIAID) invites applications that propose the complete planning, design, and preparation of documentation necessary for implementation of investigator-initiated clinical trials.  The trials must be hypothesis-driven, milestone-defined, related to the research mission of the NIAID and considered high priority by the Institute.  Investigators are encouraged to visit the NIAID website for additional information about the research mission and high-priority research areas of the NIAID.

---

NIH NIAID Clinical Trial Implementation Cooperative Agreement (U01)

Application Due Date(s) for AIDS & Non-AIDS: July 22, 2010; September 13, 2010; January 13, 2011; May 13, 2011; September 13, 2011; January 13, 2012; May 14, 2012; September 13, 2012; January 14, 2013

Website: NIH.gov posting

Purpose: The purpose of this Funding Opportunity Announcement (FOA) issued by the National Institute of Allergy and Infectious Diseases (NIAID) is to invite applications that propose implementation of investigator-initiated high-risk clinical trials.  The trials must be hypothesis-driven, related to the research mission of the NIAID and considered a high priority by the Institute.  Investigators are encouraged to visit the NIAID website for additional information about the research mission and high-priority research areas of the NIAID http://www3.niaid.nih.gov/about/whoWeAre/planningPriorities/.)  Only one clinical trial may be proposed in each NIAID Clinical Trial Implementation (U01) Cooperative Agreement application.

---

NIH NIAID Clinical Trial Implementation Grant (R01)

Application Due Date(s) for AIDS & Non-AIDS: July 22, 2010; September 13, 2010; January 13, 2011; May 13, 2011; September 13, 2011; January 13, 2012; May 14, 2012; September 13, 2012; January 14, 2013

Website: NIH.gov posting

Purpose: The purpose of this Funding Opportunity Announcement (FOA) issued by the National Institute of Allergy and Infectious Diseases (NIAID) is to invite applications that propose implementation of investigator-initiated non-high-risk clinical trials.  The trials must be hypothesis-driven, related to the research mission of the NIAID and considered a high priority by the Institute.  Investigators are encouraged to visit the NIAID website for additional information about the research mission and high-priority research areas of the NIAID http://www3.niaid.nih.gov/about/whoWeAre/plan ningPriorities/.)  Only one clinical trial may be proposed in each NIAID Clinical Trial Implementation (R01) Grant application.

---

NSF Strategic Technologies for CyberInfrastructure

Application Deadlines: August 5, 2010, First Thursday in August, Annually Thereafter; February 03, 2011 First Thursday in February, Annually Thereafter

Website: Grants.gov posting

Purpose: The primary goal of the Strategic Technologies for Cyberinfrastructure (STCI) Program is to support activities that lead to innovative cyberinfrastructure but are not currently funded by other programs or solicitations. Eligible projects include development, deployment, research, and education necessary to create cyberinfrastructure, or creation of cyberinfrastructure that will enable innovative science and education. Proposals submitted to STCI should demonstrate a significant potential to transform multiple areas of science and/or education that depend on the development and deployment of CI.

---

NIH Global Infectious Disease Research Training Program Award (D43)

Letter of Intent Due: August 14, 2010

Website: NIH.gov posting

Purpose: The purpose of this announcement is to invite applications for U.S. and developing country institutions for programs to provide infectious disease (excluding HIV/AIDS) research training to scientists and health professionals in order to build sustainable research capacity at institutions in low- and middle-income endemic countries.

---

NIH Planning Grants for Pivotal Clinical Trials in Hemoglobinopathies (R34)

Letter of Intent Due: August 16, 2010

Website: Grants.gov posting

Purpose: This FOA issued by the National Heart, Lung, and Blood Institute, National Institutes of Health, solicits Clinical Trial Planning Grant (R34) applications from institutions/organizations that propose to support the development of studies that will answer research questions essential for the design of robust clinical trials, in particular, Phase II and/or III clinical trials in the major hemoglobinopathies, sickle cell disease (SCD), and the thalassemias.

---

AHRQ Small Grant Program for Conference Support (R13)

Application Deadlines in 2010: August 20, October 20, December 20

Website: NIH posting

Purpose: The Agency for Healthcare Research and Quality (AHRQ), announces its continued interest in supporting conferences through its Small Grant Program for Conference Support. AHRQ seeks to support conferences that help to further its mission to improve the quality, safety, efficiency, and effectiveness of health care for all Americans. The types of conferences eligible for support include: 1) Research development - conferences where issues or challenges in the practice and delivery of health care are defined and a research agenda or strategy for studying them is developed; 2) Research design and methodology - conferences where methodological and technical issues of major importance in the field of health services research are addressed or new designs and methodologies are developed; 3) Dissemination and implementation conferences - where research findings and evidence-based information and tools are summarized, communicated and used by organizations and individuals that have the capability to use the information to improve the outcomes, quality, access to, and cost and utilization of health care services; and/or, 4) Research training, infrastructure and career development -conferences where faculty, trainees and students are brought together with stakeholders to develop, share or disseminate research products, experiences, curricula, syllabi, training competencies.

---

NIH Institutional Training for a Dental and Craniofacial Research Workforce (T90/R90)

Letters of Intent Receipt Date(s): August 25, 2010, 2011, 2012

Website: NIH.gov posting

Purpose: The National Institute of Dental and Craniofacial Research (NIDCR) will award T90/R90 grants to eligible institutions that are committed to supporting predoctoral and postdoctoral research training as a means to help ensure that a diverse and highly trained workforce is available to address the Nation’s health related needs in dental, oral, and craniofacial research.  This NIDCR program is designed in recognition of the need to develop a cadre of highly qualified independent scientists who can successfully address basic, behavioral, and clinical research questions to improve oral, dental and craniofacial health. Trainees are required to pursue full-time research training.  Priority will be given to programs that present plans and evidence that they will train dentist scientists either as predoctoral dual degree dentist scientists, dentists receiving PhD training or dentists training in a postdoctoral research experience.

---

NIH Ruth L. Kirschstein National Research Service Award (NRSA) Institutional Training for a Dental and Craniofacial Research Workforce (T32)

Letters of Intent Receipt Date(s): August 25, 2010, 2011, 2012

Website: NIH.gov posting

Purpose: The National Institute of Dental and Craniofacial Research (NIDCR) will award T32 Institutional Training grants to eligible institutions that are committed to supporting predoctoral and postdoctoral research training as a means to help ensure that a diverse and highly trained workforce is available to address the Nation’s health related needs in dental, oral, and craniofacial research.  This NIDCR program is designed in recognition of the need to develop a cadre of highly qualified independent scientists who can successfully address basic, behavioral, and clinical research questions to improve oral, dental and craniofacial health. Trainees are required to pursue full-time research training.  Priority will be given to programs that present plans and evidence that they will train dentist scientists either as predoctoral dual degree dentist scientists, dentists receiving PhD training or dentists training in a postdoctoral research experience.

---

NIH/NCI Validation and Advanced Development of Emerging Technologies
for Cancer Research (R33)

Letter of Intent Receipt Date: August 30, 2010 

Website: NIH posting

Purpose: This Funding Opportunity Announcement (FOA), issued by the National Cancer Institute (NCI), National Institutes of Health (NIH), solicits grant applications proposing research projects on the advanced development of emerging molecular and cellular analysis technologies through technical/analytical validation in an appropriate cancer-relevant biological system. An “emerging technology” is defined as one that has passed the pilot developmental stage and shows promise, but has not yet been evaluated within the context of its intended use. If successful, these technologies would accelerate research in cancer biology, cancer treatment and diagnosis, cancer prevention, cancer control and epidemiology, and/or cancer health disparities. This FOA solicits R33 applications; this mechanism is suitable for projects where “proof-of-principle” of the proposed technology or methodology has been established and supportive preliminary data are available. Projects proposed to this FOA should reflect the potential to produce a major impact in a broad area of cancer-relevant research. Projects proposing to use established technologies where the novelty resides in the biological or clinical question being pursued are not appropriate for this solicitation and will be returned as non-responsive. This funding opportunity is part of a broader NCI-sponsored Innovative Molecular Analysis Technologies (IMAT) Program.

---

NIH/NCI Application and Early Stage Development of Emerging Technologies in
Cancer Research (R21)

Letter of Intent Receipt Date: August 30, 2010 

Website: Grants.gov posting

Purpose: This Funding Opportunity Announcement (FOA), issued by the National Cancer Institute (NCI), National Institutes of Health (NIH), solicits grant applications that propose exploratory research projects on the initial application of emerging analytical technologies as laboratory or clinical tools. An “emerging technology” is defined as one that has passed the initial developmental stage, but has not yet been evaluated within the context of its intended use. Projects proposed in response to this FOA should have the potential to produce a major impact in a broad area of cancer-relevant research. If successful, these technologies would accelerate research in cancer biology, cancer treatment and diagnosis, cancer prevention, cancer control and epidemiology, and/or cancer health disparities. This FOA solicits R21 applications that have high potential impact and allows for an element of technical risk; preliminary data are not required. All projects must include quantitative milestones (i.e. technical metrics that determine whether the specific aims have been accomplished). Projects proposing to use established technologies where the novelty resides in the biological or clinical question being pursued are not appropriate for this solicitation and will be returned as non-responsive. This funding opportunity is part of a broader NCI-sponsored Innovative Molecular Analysis Technologies (IMAT) Program.

---

NIH/NCI Innovative Technology Development for Cancer Research (R21)

Letter of Intent Receipt Date: August 30, 2010 

Website: Grants.gov posting

Purpose: This Funding Opportunity Announcement (FOA) issued by the National Cancer Institute (NCI), National Institutes of Health (NIH), solicits grant applications proposing technically innovative feasibility studies focused on early stage development of cancer-relevant technologies. If successful, these technologies would accelerate the research and understanding of basic cancer biology, cancer treatment and diagnosis, cancer prevention, cancer control and epidemiology, and/or cancer health disparities. This FOA solicits R21 applications and is suitable for projects at their inception, conceptual or idea based, where technical feasibility of the proposed technology or methodology has not yet been established. The R21 mechanism requires high potential impact and allows for an element of technical risk; projects proposed in response to this FOA may reflect this level of risk but must have concurrent potential to produce a major impact in a broad area of cancer-relevant research. All projects must include quantitative milestones (i.e. technical metrics that determine whether the specific aims have been accomplished). Projects proposing to use technology that is already established or projects where the novelty resides in the biological or clinical question being pursued are examples of topics not appropriate for this solicitation and will be returned as non-responsive. This funding opportunity is part of a broader NCI-sponsored Innovative Molecular Analysis Technologies (IMAT) Program.

---

NIH Development of Outcome Measures to Determine Success of Hearing Health Care (R01)

Letters of Intent Due Date(s): September 1, 2010, May 1, 2011, January 1, 2012

Website: NIH.gov posting

Purpose: This FOA, issued by the National Institute on Deafness and Other Communication Disorders, National Institutes of Health, encourages Research Project Grant (R01) applications from institutions/organizations that propose to develop and evaluate a set of outcome measures to determine the success of hearing health care for adults with hearing loss.  There is a compelling need to identify the variables contributing to successful hearing health care outcomes, particularly the patient-centered and instrument-centered variables contributing to successful hearing aid use.

---

NIH Accessible and Affordable Hearing Health Care (R21/R33)

Letter of Intent Due: September 8, 2010

Website: NIH.gov posting

Purpose: This funding opportunity announcement (FOA) issued by National Institute on Deafness and Other Communication Disorders (NIDCD) invites Exploratory/Developmental Phased Innovation (R21/R33) grant applications from organizations/institutions to support research and/or infrastructure needs leading to accessible and affordable hearing health care (HHC).  Applications may request research and/or infrastructure support.  This FOA seeks milestone-driven research applications exploring new or innovative adaptations of approaches designed to increase access and affordability of hearing health care.  Applications should be focused on delivering better healthcare access and outcomes and should seek solutions that are effective, affordable and deliverable to those who need them. This FOA uses the R21/R33 grant mechanism and requires a separate statement that justifies the need for the mechanism and describes anticipated milestones.

---

NIH Institutional Clinical and Translational Science Award (U54)

Letter of Intent Due: September 14, 2010

Website: NIH.gov posting

Purpose: The Clinical and Translational Science Award (CTSA) initiative assists institutions to create an integrated academic home for Clinical and Translational Science that has the resources to train and advance multi- and inter-disciplinary investigators and research teams with access to innovative research tools and information technologies that apply new knowledge and techniques to patient care. Clinical and Translational Science Awards (CTSAs) attract basic, translational, and clinical investigators, community clinicians, clinical practices, networks, professional societies, and industry to develop new professional interactions, programs, and research projects. Through innovative advanced degree programs, CTSAs foster the discipline of Clinical and Translational Science that is broader and deeper than their separate components (definitions of Clinical and Translational Science are provided in Section I of this posting).

---

NSF Macrosystems Biology

Full Proposal Deadline(s): September 16, 2010; April 04, 2011; First Monday in April, Annually Thereafter

Website: Grants.gov posting

Purpose: The Macrosystems Biology: Research on Biological Systems at Regional to Continental Scales will support quantitative, interdisciplinary, systems-oriented research on biosphere processes and their complex interactions with climate, land use, and invasive species at regional to continental scales as well as planning and development activities to enable groups to conduct Macrosystems Biology Research.

---

HHS, NIH: In vivo Cellular and Molecular Imaging Centers (ICMICs) (P50) Grant

Application Submission Windows:
Letters of Intent Deadline(s): September 28, 2010; September 28, 2011
Application Deadline(s): October 28, 2010; October 28, 2011 

Website: Grants.gov posting

Purpose: The program will fund the 5-year P50 ICMIC grants to support interdisciplinary scientific teams conducting cutting-edge cancer molecular imaging research. ICMIC funding is designed to: (1) support innovative cancer molecular imaging research projects; (2) support unique core facilities; (3) enable the awardees to initiate pilot research in new promising directions; and (4) provide interdisciplinary career development opportunities for investigators new to the field of molecular cancer imaging

---

NIH Blueprint for Neuroscience Research Grand Challenge on the Transition from Acute to Chronic Neuropathic Pain (R01)

Application Deadline: September 29, 2010

Website: Grants.gov posting

Purpose: This FOA is issued as an initiative of the NIH Blueprint for Neuroscience Research.The Neuroscience Blueprint is a collaborative framework through which 16 NIH Institutes, Centers and Offices jointly support neuroscience-related research, with the aim of accelerating discoveries and reducing the burden of nervous system disorders (for further information, see http://neuroscienceblueprint.nih.gov/). The goal of this FOA is to facilitate research collaborations between pain scientists and non-pain neuroscientists with expertise in neuroplasticity in order to study biological mechanisms underlying the transition from acute to chronic pain. These collaborations will capture insights and expertise from disciplines where transitions from health to disease have been extensively examined. The purpose of this FOA is to encourage submission of multi-PI grant applications that propose highly collaborative, multidisciplinary research projects addressing neuropathic pain conditions. An expected outcome of this FOA will be the formation of partnerships between pain researchers and non-pain neuroscientists to develop new collaborations focused on understanding the maladaptive neuroplastic changes that occur during the transition from acute to chronic neuropathic pain.

---

NIH Integrated Preclinical/Clinical AIDS Vaccine Development Program (IPCAVD) (U19)

Letter of Intent Receipt Date(s): October 8, 2010; October 7, 2011; October 9, 2012
Application Receipt Date(s): November 8, 2010; November 8, 2011; November 8, 2012

Website: Grants.gov posting

Purpose: The goal of this Funding Opportunity Announcement (FOA) issued by the National Institute of Allergy and Infectious Diseases (NIAID) is to facilitate the translation of innovative and promising basic science-derived vaccine concepts for prophylactic HIV vaccines to initial clinical trials by providing the critical resources necessary for achieving this goal.  The Integrated Preclinical/Clinical AIDS Vaccine Development Program (IPCAVD) is a mechanism that enables investigators to conduct clinical research studies aimed at addressing specific scientific questions and vaccine concepts most appropriately tested in humans.  To fulfill this goal, an IPCAVD award is intended to provide assistance to meritorious competitive projects in 3 areas:  (1) support for basic hypothesis-driven science to advance development of the vaccine concept by facilitating non-human primate (NHP) proof-of-concept studies and down-selection to the best lead candidate; (2) access to resources for determining whether the vaccine concept is clinically feasible by determining whether a candidate vaccine successfully addresses FDA requirements for performing clinical testing, by determining the feasibility of manufacturing cGMP lots of the vaccine and by determining vaccine safety by conducting the required toxicology and pharmacology safety studies; and (3) support for the initial human clinical study central to addressing the proposed scientific question.  A preclinical research project application alone is not appropriate for this announcement.

---

NIH Multi-Component Youth/Young Adult Alcohol Prevention Trials (R01)

Letter of Intent Due: November 2, 2010

Website: NIH.gov posting

Purpose: This Funding Opportunity Announcement (FOA) invites research grant applications that will advance the science of alcohol prevention and treatment through evaluations of multicomponent community programs, with a specific focus on adolescents and young adults. It seeks proposals to test the relative effectiveness and costs of:  (1) Community based programs comprised of environmental interventions to reduce underage and binge drinking among young adults and related harmful behaviors; (2) Community based programs that increase alcohol screening, brief intervention, and access to formal treatment for adolescents and young adults in multiple community settings (e.g. primary care, emergency departments, school- and work-based settings, and web-based venues); and (3) Programs that combine both strategies.

---

NSF Fellowships for Transformative Computational Science using CyberInfrastructure
(CI TraCS)

Full Proposal Due Date(s): January 13, 2011; and January 13, 2012

Website: NSF.gov posting

Purpose: The overarching goal of the NSF Fellowships for Transformative Computational Science using Cyberinfrastructure (CI TRaCS) program is to support outstanding scientists and engineers who have recently completed doctoral studies and are interested in pursuing postdoctoral activities in computational science, and thereby nurturing the future leaders in this emerging and important multidisciplinary field. Computational research and education activities that are cyberinfrastrucure-based and cross disciplinary boundaries are a key focus of this program. Successful Fellows may, for example, use cyberinfrastructure to make revolutionary advances in their disciplines, and/or deploy cyberinfrastructure-based technologies that enable innovative computational practices.

 

NIH Ruth L. Kirschstein National Research Service Award (NRSA) Institutional Predoctoral Training Program in Systems Biology of Developmental Biology & Birth Defects (T32)

Letter of Intent Due: April 25, 2011, April 25, 2012

Website: NIH.gov posting

Purpose: The National Institutes of Health (NIH) awards Ruth L. Kirschstein National Research Service Award (NRSA) Institutional Research Training Grants (T32) to eligible institutions as the primary means of supporting predoctoral and postdoctoral research training to help ensure that a diverse and highly trained workforce is available to assume leadership roles related to the Nation’s biomedical, behavioral and clinical research agenda.  The primary objective of the T32 program is to prepare qualified individuals for careers that have a significant impact on the health-related research needs of the Nation. This Funding Opportunity Announcement (FOA) issued by the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) encourages applications for predoctoral NRSA T32s to provide research training in systems biology of developmental biology and/or structural birth defects research.

---

NIH Centers of Research Translation (P50)

Letter of Intent Due: May 10, 2011

Website: NIH.gov posting

Purpose: This Funding Opportunity Announcement (FOA), issued by the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), invites applications for Centers of Research Translation (CORT) (P50). It is expected that a CORT will have a disease-targeted translational theme with individual projects providing synergy for the theme, directed at elucidating the relevance of basic research to human disease in an area within the NIAMS mission. Two major features of the CORT program include: 1) the overarching aim of disease-specific research translation, and 2) the inclusion of resources and an administrative structure to facilitate research translation.

---

NIH, The NEI Mentored Clinical Scientist Development Program Award (K12)

Application Due Date(s): May 13, 2011

Website: NIH.gov posting

Purpose: The purpose of the NEI Mentored Clinical Scientist Development Program Award (K12) is to facilitate and support the career development of clinical vision scientists who have made a commitment to independent research careers.

---

NIH MARC Undergraduate Student Training in Academic Research (U-STAR) National Research Service Award (NRSA) Institutional Research Training Grant (T34)

Application Due Date(s):  May 25, 2011, 2012

Website: NIH.gov posting

Purpose: The National Institute of General Medical Sciences (NIGMS) will award Minority Access to Research Careers (MARC) Undergraduate Student Training in Academic Research (U-STAR) National Research Service Act (NRSA) Training grants to eligible institutions as a means of supporting undergraduate academic and research training to help ensure that a diverse and highly trained workforce is available to assume leadership roles related to the Nation’s biomedical and behavioral research agenda.  The MARC U-STAR program is designed to have a significant impact on the health-related research needs of the Nation by providing support  to students underrepresented in the biomedical and behavioral sciences and improving their preparation for highly selective Ph.D. level training and future careers.  The program supports efforts to strengthen the science/math course curricula, pedagogical skills of faculty, and biomedical research training at institutions with significant enrollments of students from underrepresented groups.

---

NIH Paul Calabresi Career Development Award for Clinical Oncology (K12)

Application Due Dates: June 10, 2011; June 11, 2012

Website: NIH.gov posting

Purpose: This funding opportunity announcement (FOA) issued by the National Cancer Institute (NCI) encourages applications for institutional research career development (K12) programs from applicant organizations that propose to promote the training and career development of translational and clinical trials researchers. The purpose of the Paul Calabresi Career Development Award in Clinical Oncology (PCACO) K12 (NIH Institutional Research Career Development K12 grant mechanism) is to increase the number of clinicians (M.D.s, D.O.s, Pharm.D.s) and basic research scientists (Ph.D.s. or equivalents) who are trained to design and administer hypothesis-based pilot/Phase I, Phase II, and Phase III cancer therapeutic clinical trials in team research settings. A PCACO can support the research career development of clinicians only (single-track program) or clinicians and Ph.D. basic research scientists (dual-track program). Clinical and basic research scientists will collaborate and interact to expedite the translation of basic science research discoveries into patient-oriented therapeutic cancer research. The PCACO is not intended to train laboratory-based scientists whose research will be primarily focused upon the use of animal or other model systems. 

---

HHS, NIH: Rapid Assessment Post-Impact of Disaster Grants (R03) & (R21)

Application Accepted Through: April 22, 2012  

Website: Grants.gov (R03 grant) posting, award ceiling $50,000.

Grants.gov (R21 grant) posting, award ceiling $200,000.

Purpose: These grants are to provide a rapid funding mechanism for research on the post-impact of disasters, in order to permit access to a disaster area in the immediate aftermath of the event.

---

AHRQ Grant Program for Large or Recurring Conferences (R13)

Application Accepted Through: January 7, 2013

Website: Grants.gov posting

Purpose: The Agency for Healthcare Research and Quality (AHRQ), announces its continued interest in supporting conferences through its Large or Recurring Grant Program for Conference Support. AHRQ seeks to support conferences that help to further its mission to improve the quality, safety, efficiency, and effectiveness of health care for all Americans. The types of conferences eligible for support include: 1) Research development - conferences where issues or challenges in the practice and delivery of health care are defined and a research agenda or strategy for studying them is developed; 2) Research design and methodology - conferences where methodological and technical issues of major importance to the field of health services research are addressed or new designs and methodologies are developed; 3) Dissemination and implementation - conferences where research findings and evidence-based information and tools are summarized, communicated and used by organizations and individuals that have the capability to use the information to improve the outcomes, quality, access to, and cost and utilization of health care services; and/or, 4) Research training, infrastructure and career development -conferences where faculty, trainees and students are brought together with stakeholders to develop, share or disseminate research products, experiences, curricula, syllabi, or training competencies. AHRQ is especially interested in supporting conferences that include plans for disseminating complimentary conference materials and products beyond the participants attending the event. Such strategies might include, but are not limited to, submitting articles for publication, posting information on a Web site, and seeking formal opportunities to discuss conference information with others.

---

AHRQ Partnerships in Implementing Patient Safety II (R18)

Application Accepted Through: January 8, 2013

Website: Grants.gov posting

Purpose: The purpose of this Funding Opportunity (FOA) is to support Research Demonstration and Dissemination (R18) grant applications from organizations that will implement safe practice interventions that demonstrate evidence of reducing or eliminating medical errors, risks, hazards, and harms associated with the process of health care. These 24 month implementation projects will inform AHRQ, providers, patients, payers, policy makers, and the public about how safe practice interventions can be successfully implemented in diverse health care settings and lead to safer and better health care for all Americans.  This FOA follows the release of an earlier FOA in 2005 that resulted in the release of successful implementation projects and toolkits available to the public.  Background information on the earlier FOA can be found at http://grants1.nih.gov/grants/guide/FOA-files/FOA-HS-05-012.html.  Examples of and Information on projects from the initial Partnerships in Implementing Patient Safety FOA can be found at http://www.ahrq.gov/qual/pips/.